Extended-spectrum beta-lactamase-mediated resistance among bacterial isolates recovered from ocular infections

Ophthalmic Research

Volumn 47, Issue 1, 2011, Pages 52-56

  Bharathi, M Jayahar ^a   Ramakrishnan, R ^a   Ramesh, S ^b   Murugan, N ^a  

^a ARAVIND EYE HOSPITAL   (India)

^b SRI PARAMAKALYANI COLLEGE   (India)

Author keywords

AmpC lactamase mediated resistance; Extended spectrum lactamase, E test; Extended spectrum lactamase, phenotypic tests; Extended spectrum lactamase mediated resistance; Gram negative ocular isolates

Indexed keywords

BETA LACTAMASE AMPC; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL EYE INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CEFTAZIDIME AEGYPTICUS; DISK DIFFUSION; ENTEROBACTER AEROGENES; EPSILOMETER TEST; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS PARAINFLUENZAE; HUMAN; HUMAN TISSUE; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TEST; NONHUMAN; PANTOEA AGGLOMERANS; PRIORITY JOURNAL; PROTEUS MIRABILIS; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CEFOTAXIME; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EYE INFECTIONS, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; PROSPECTIVE STUDIES;

EID: 79959631403     PISSN: 00303747     EISSN: 14230259     Source Type: Journal    
DOI: 10.1159/000322807     Document Type: Article

References (7)

1. Paterson DL, Bonomo RA: Extended-spectrum-lactamases: a clinical update. Clin Microbiol Rev 2005; 18: 657-686.
2. Byrne KA, Burd E, Tabbara K, Hyndiuk R: Diagnostic Microbiology and Cytology of the Eye. Boston, Butterworth Heinemann, 1995.
3. Clinical Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing; 17th informational supplement. CLSI document M100-S17. M2-A9-performance standards for antimicrobial disk susceptibility tests: approved standard, 19th ed. Clinical Laboratory Standards Institute, 2007, vol 27.
4. Singhal S, Mathur T, Khan S, Upadhya DJ, Chugh S, Gaind R, Rattan A: Evaluation of methods for AmpClactamases in Gram negative clinical isolates from tertiary care hospitals. Indian J Med Microbiol 2005; 23: 120-124. (Pubitemid 40712521)
5. Bonnet R: Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004; 48: 1-14. (Pubitemid 38040170)
6. Jones RN, Rhomberg PR, Varman DJ, Mathai D: A comparison of the antimicrobial activity of meropenem and selected broad-spectrum antimicrobials tested against multidrug resistant Gram-negative bacilli including bacteraemic Salmonella spp. Initial studies for MYSTIC Program in India. Int J Antimicrob Agents 2002; 20: 426-431. (Pubitemid 35379982)
7. Kumar MS, Lakshmi V, Rajagopalan R: Occurrence of extended spectrum-lactamases among Enterobacteriaceae spp. isolated at a tertiary care institute. Indian J Med Microbiol 2006; 24: 208-211. (Pubitemid 44315655)